Literature DB >> 21499169

The association between the end tidal alveolar dead space fraction and mortality in pediatric acute hypoxemic respiratory failure.

Anoopindar K Ghuman1, Christopher J L Newth, Robinder G Khemani.   

Abstract

OBJECTIVE: To investigate the relationship of markers of oxygenation, PaO2/FIO2 ratio, SpO2/FIO2 ratio, oxygenation index, oxygen saturation index, and dead space (end tidal alveolar dead space fraction) with mortality in children with acute hypoxemic respiratory failure.
DESIGN: Retrospective.
SETTING: Single-center tertiary care pediatric intensive care unit. PATIENTS: Ninety-five mechanically ventilated children with a PaO2/FIO2 ratio <300 within 24 hrs of the initiation of mechanical ventilation.
INTERVENTIONS: None. MAIN
RESULTS: The end tidal alveolar dead space fraction, PaO2/FIO2 ratio, SpO2/FIO2 ratio, oxygenation index, and oxygen saturation index were all associated with mortality (p < .02). There was a small correlation between the end tidal alveolar dead space fraction and decreasing PaO2/FIO2 (r2 = .21) and SpO2/FIO2 ratios (r2 = .22), and increasing oxygenation index (r2= .25) and oxygen saturation index (r2 = .24). In multivariate logistic regression modeling, the end tidal alveolar dead space fraction was independently associated with mortality (p < .02). Oxygenation index, oxygen saturation index, and the end tidal alveolar dead space fraction were all acceptable discriminators of mortality with receiver operating characteristic plot area under the curves ≥ 0.7.
CONCLUSIONS: In pediatric acute hypoxemic respiratory failure, easily obtainable pulmonary specific markers of disease severity (SpO2/FIO2 ratio, oxygen saturation index, and the end tidal alveolar dead space fraction) may be useful for the early identification of children at high risk of death. Furthermore, the end tidal alveolar dead space fraction should be considered for risk stratification of children with acute hypoxemic respiratory failure, given that it was independently associated with mortality.

Entities:  

Mesh:

Year:  2012        PMID: 21499169     DOI: 10.1097/PCC.0b013e3182192c42

Source DB:  PubMed          Journal:  Pediatr Crit Care Med        ISSN: 1529-7535            Impact factor:   3.624


  14 in total

1.  Evaluating the Berlin Definition in pediatric ARDS.

Authors:  Robinder G Khemani; Douglas F Wilson; Andrés Esteban; Niall D Ferguson
Journal:  Intensive Care Med       Date:  2013-10-08       Impact factor: 17.440

2.  Surviving sepsis campaign international guidelines for the management of septic shock and sepsis-associated organ dysfunction in children.

Authors:  Scott L Weiss; Mark J Peters; Waleed Alhazzani; Michael S D Agus; Heidi R Flori; David P Inwald; Simon Nadel; Luregn J Schlapbach; Robert C Tasker; Andrew C Argent; Joe Brierley; Joseph Carcillo; Enitan D Carrol; Christopher L Carroll; Ira M Cheifetz; Karen Choong; Jeffry J Cies; Andrea T Cruz; Daniele De Luca; Akash Deep; Saul N Faust; Claudio Flauzino De Oliveira; Mark W Hall; Paul Ishimine; Etienne Javouhey; Koen F M Joosten; Poonam Joshi; Oliver Karam; Martin C J Kneyber; Joris Lemson; Graeme MacLaren; Nilesh M Mehta; Morten Hylander Møller; Christopher J L Newth; Trung C Nguyen; Akira Nishisaki; Mark E Nunnally; Margaret M Parker; Raina M Paul; Adrienne G Randolph; Suchitra Ranjit; Lewis H Romer; Halden F Scott; Lyvonne N Tume; Judy T Verger; Eric A Williams; Joshua Wolf; Hector R Wong; Jerry J Zimmerman; Niranjan Kissoon; Pierre Tissieres
Journal:  Intensive Care Med       Date:  2020-02       Impact factor: 17.440

3.  Pulse oximetry vs. PaO2 metrics in mechanically ventilated children: Berlin definition of ARDS and mortality risk.

Authors:  Robinder G Khemani; Sarah Rubin; Sanjay Belani; Dennis Leung; Simon Erickson; Lincoln S Smith; Jerry J Zimmerman; Christopher J L Newth
Journal:  Intensive Care Med       Date:  2014-09-18       Impact factor: 17.440

Review 4.  Biomarkers in pediatric acute respiratory distress syndrome.

Authors:  Erin F Carlton; Heidi R Flori
Journal:  Ann Transl Med       Date:  2019-10

5.  Volumetric Capnography in Pediatric Extracorporeal Membrane Oxygenation: A Case Series.

Authors:  Kim R Derespina; Shivanand S Medar; Scott I Aydin; Shubhi Kaushik; Awni Al-Subu; George Ofori-Amanfo
Journal:  J Pediatr Intensive Care       Date:  2020-10-05

6.  Alveolar Dead Space Fraction Discriminates Mortality in Pediatric Acute Respiratory Distress Syndrome.

Authors:  Nadir Yehya; Anoopindar K Bhalla; Neal J Thomas; Robinder G Khemani
Journal:  Pediatr Crit Care Med       Date:  2016-02       Impact factor: 3.624

Review 7.  An Official American Thoracic Society/European Respiratory Society Workshop Report: Evaluation of Respiratory Mechanics and Function in the Pediatric and Neonatal Intensive Care Units.

Authors:  Stacey Peterson-Carmichael; Paul C Seddon; Ira M Cheifetz; Inéz Frerichs; Graham L Hall; Jürg Hammer; Zoltán Hantos; Anton H van Kaam; Cindy T McEvoy; Christopher J L Newth; J Jane Pillow; Gerrard F Rafferty; Margaret Rosenfeld; Janet Stocks; Sarath C Ranganathan
Journal:  Ann Am Thorac Soc       Date:  2016-02

8.  Acute effect of inhaled iloprost on exercise dynamic hyperinflation in COPD patients: A randomized crossover study.

Authors:  Matthew R Lammi; Mohamed A Ghonim; Jessica Johnson; Johnny D'Aquin; John B Zamjahn; Andy Pellett; Samuel C Okpechi; Connie Romaine; Kusma Pyakurel; Hahn H Luu; Judd E Shellito; A Hamid Boulares; Bennett P deBoisblanc
Journal:  Respir Med       Date:  2021-03-08       Impact factor: 3.415

9.  The Use of Alveolar Dead Space Fraction to Predict Postoperative Outcomes after Pediatric Cardiac Surgery: A Retrospective Study.

Authors:  Imran A Sayed; Scott Hagen; Victoria Rajamanickam; Petros V Anagnostopoulos; Marlowe Eldridge; Awni Al-Subu
Journal:  Pediatr Cardiol       Date:  2021-07-09       Impact factor: 1.655

Review 10.  BPD Following Preterm Birth: A Model for Chronic Lung Disease and a Substrate for ARDS in Childhood.

Authors:  Anita Bhandari; Christopher Carroll; Vineet Bhandari
Journal:  Front Pediatr       Date:  2016-06-15       Impact factor: 3.418

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.